SCHEMBL7150268

SCHEMBL7150268

C=CCOC(=O)NC(CCCC)c1cccc(NS(=O)(=O)c2cccc(N)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.41
HTR6 P50406 2/20 0.39
ADRB2 P07550 3/20 0.38
ADRB1 P08588 3/20 0.38
ADRB3 P13945 3/20 0.38
KMT2A Q03164 3/20 0.38
PKM P14618 3/20 0.38
LMNA P02545 3/20 0.37
MEN1 O00255 2/20 0.37
MAPT P10636 2/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
WDR5 P61964 1/20 0.36
ALDH1A1 P00352 2/20 0.36
XBP1 P17861 1/20 0.36
MAPK1 P28482 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3809843 0.87 POLB (0.40) POLBHTR6ADRB2ADRB1ADRB3
SCHEMBL7143100 0.87 KMT2A (0.51) KMT2APKMLMNAMEN1MAPT
SCHEMBL7148744 0.82 HTR6 (0.43) POLBHTR6ADRB2ADRB1ADRB3
SCHEMBL4954940 0.75 MAPT (0.42) ADRB3PKMMAPTALDH1A1SMN1; SMN2
SCHEMBL3811615 0.74 ALDH1A1 (0.53) KMT2APKMLMNAMEN1MAPT
SCHEMBL23795546 0.72 POLB (0.47) POLBHTR6ADRB2ADRB1ADRB3
SCHEMBL31026026 0.72 POLB (0.47) POLBHTR6ADRB2ADRB1ADRB3
SCHEMBL23795545 0.72 POLB (0.47) POLBHTR6ADRB2ADRB1ADRB3
SCHEMBL7148734 0.72 POLB (0.43) POLBHTR6KMT2APKMLMNA
SCHEMBL3841758 0.72 POLB (0.39) POLBHTR6ADRB2ADRB1ADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1347783-A1 CONJUGATES OF INTEGRIN RECEPTOR ANTAGONISTS AND A CYTOSTATIC AGENT HAVING SPECIFICALLY CLEAVABLE LINKING UNITS Bayer Aktiengesellschaft (DE) 2003-10-01 EP disclosed
WO-2002051444-A1 CONJUGATES OF INTEGRIN RECEPTOR ANTAGONISTS AND A CYTOSTATIC AGENT HAVING SPECIFICALLY CLEAVABLE LINKING UNITS BAYER AKTIENGESELLSCHAFT (DE) 2002-07-04 WO disclosed